All News
All series
All All News
Advertisement
Cost of cancer care is a growing concern of both patients and medical professionals.
Ponatinib continues to make improvements in phase 2 CML study.
Velcade-based therapy shows benefit in multiple myeloma trial called GIMEMA.
A study shows that a chemotherapy-free regimen may be better in acute promyelocytic leukemia.
Find information and resources on Medicare.
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
3
Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us
4
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
5